90-Yttrium-ibritumomab Tiuxetan As First-Line Treatment for Follicular Lymphoma: Updated Efficacy and Safety Results at an Extended Median Follow-Up of 9.6 Years
Annals of Hematology(2022)
Key words
Follicular lymphoma,First-line therapy,90-yttrium-ibritumomab tiuxetan,90Y-IT
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined